References
Pavlou, A. K. & Belsey, M. J. From the analyst's couch: Biopharma licensing and M&A trends. Nature Rev. Drug Discov. 4, 273–274 (2005).
PriceWaterhouseCoopers. High-performing strategic alliances in the pharmaceutical, biotechnology and medical device and diagnostic industries, [online] (1999)
Kogut, B. in Co-operative Strategies in International Business (eds Contractor, F. J. & Lorange, P.) 169–185 (Lexington, Massachusetts, 1988).
Jones, A. & Clifford, L. From the analyst's couch: Drug discovery alliances. Nature Rev. Drug Discov. 4, 807–808 (2005).
DiMasi, J. A. Risks in new drug development: approval success rates for investigational drugs. Clin. Pharmacol. Ther. 69, 297–307 (2001).
Gambardella, A., Orsenigo, L. & Pammolli, F. Global competitiveness in pharmaceuticals: a European perspective, [online] (2001).
CMR International 2005/2006 Pharmaceutical R&D Fact Book. Centre for Medicines Research International Ltd, [online] (2005).
Author information
Authors and Affiliations
Related links
Rights and permissions
About this article
Cite this article
Lou, K., Rond, M. The 'not invented here' myth. Nat Rev Drug Discov 5, 451–452 (2006). https://doi.org/10.1038/nrd2063
Issue Date:
DOI: https://doi.org/10.1038/nrd2063
- Springer Nature Limited
This article is cited by
-
Minimizing leakage of value from R&D alliances
Nature Reviews Drug Discovery (2007)
-
What's wrong with drug screening today
Nature Chemical Biology (2007)